Last week, a year after the launch of TissuePatchDural onto the French market, Tissuemed returned to the beautiful surroundings of Versailles to join Sophysa for the annual meeting the French-Speaking Society of Neurosurgeons (SNCLF). The event was well attended by neurosurgeons from across France and there was considerable interest on Sophysa’s booth.
For Tissuemed, David Mandley commented, “Over the last 12 months Sophysa have made good progress in securing new business for TissuePatchDural in France. The publication of positive comparative clinical data demonstrating effective watertight dural closure in high-risk posterior fossa surgery will help support Sophysa’s sales efforts.”
For further information on TissuePatchDural please clickhere.
For further information about the TissuePatch product family and potential collaborative opportunities including distribution please contact Tissuemed at email@example.com